Osivax gets €10M influenza vaccine grant
A grant of €10 million ($10.5 million) has been secured by pharmaceutical company Osivax to…
23/06/2022 - 2 minutes
News and Trends
Scancell to produce and clinically validate T cell redirecting bispecific antibodies
Scancell Holdings plc, which develops immunotherapies for the treatment of cancer and infectious disease, has…
23/06/2022 - 3 minutes
Krystal Biotech looks for FDA approval for dystrophic epidermolysis bullosa treatment
U.S. gene therapy company Krystal Biotech, Inc, has submitted a Biologics License Application (BLA) to…
23/06/2022 - 3 minutes
Gemelli Biotech to work on gastrointestinal diseases with new $19M funding
U.S.-headquartered Gemelli Biotech Corp, which focuses on precision diagnostics for gastrointestinal (GI) diseases, has completed…
23/06/2022 - 3 minutes
BRIM Biotechnology enters OTC trading in Taiwan
BRIM Biotechnology, Inc.has entered OTC (over the counter) trading in Taiwan. Established in July 2013,…
23/06/2022 - 3 minutes
Shanghai biotech secures $80 million to advance products
A bio-manufacturing company based in Shanghai has bagged $80 million in funding to advance its…
23/06/2022 - 2 minutes
Roquefort Therapeutics buys UK biotech in return for shares
Medical biotechnology company, Roquefort Therapeutics, has conditionally agreed to buy UK biotech Oncogeni Ltd in…
22/06/2022 - 2 minutes
Millions invested for progression of Lyme disease vaccine
Pfizer has agreed to invest €90.5 million ($95 million) towards a vaccination for Lyme disease. …
22/06/2022 - 2 minutes
US Toddlers and children to receive Covid-19 vaccine after emergency approval granted
Emergency authorization was granted for the use of the Pfizer-BioNTech Covid-19 vaccines on children from…
22/06/2022 - 3 minutes
Rensselaer researchers make face masks to fight viruses
Researchers at Rensselaer Polytechnic Institute in Troy, NY, have developed N95 surgical face masks that…
22/06/2022 - 3 minutes
Cystic fibrosis in the crosshairs as Carbon Biosciences launches with $38M funding
Carbon Biosciences, a Longwood Fund founded biotech company developing parvovirus-derived gene therapies, has launched with…
22/06/2022 - 3 minutes
From mugwort allergy to an effective vaccine?
A research team at MedUni Vienna in Austria says it has discovered key mechanisms of…
22/06/2022 - 2 minutes
